UC San Diego Cardiology
@UCSDCardiology
Followers
811
Following
676
Media
150
Statuses
966
Official Twitter account for the Division of Cardiovascular Medicine at UC San Diego School of Medicine
La Jolla, CA
Joined July 2022
Congratulations to the class of 2025!
What an amazing night celebrating the graduating @UCSDCardiology fellows of 2025. We are so proud of you all and are excited to see your careers blossom! 🫀🎓🍾🍻
0
1
12
Congratulations to our newest fellows! Looking forward to working with each of you!
We are thrilled to announce our fellowship match results and to welcome an outstanding new class to the @UCSDCardFellows family! @UCSDHealthSci @ucsdim @hsbhatia @loridanielsmd
0
1
4
Congratulations to my mentee Yash on matching cardiology at a dream institution!! @UCSDCardFellows just gained a rockstar dedicated to advancing the field. @_yprak_
We are thrilled to announce our fellowship match results and to welcome an outstanding new class to the @UCSDCardFellows family! @UCSDHealthSci @ucsdim @hsbhatia @loridanielsmd
0
3
29
Still in disbelief. After 3 incredible years with @DOMSinaiNYC, I am ecstatic to join @UCSDCardiology for 🫀 fellowship! Couldn’t have done it without the support of @MountSinaiHeart. Special thank you to @waqasmalick5, @AliZaidiMD, @DLBHATTMD, & Dr. Stamatios Lerakis!!
We are thrilled to announce our fellowship match results and to welcome an outstanding new class to the @UCSDCardFellows family! @UCSDHealthSci @ucsdim @hsbhatia @loridanielsmd
11
1
68
We are thrilled to announce our fellowship match results and to welcome an outstanding new class to the @UCSDCardFellows family! @UCSDHealthSci @ucsdim @hsbhatia @loridanielsmd
0
3
59
We have a new paper on @OxPL_apoB (using the automated Diazyme- @BostonHeartDX method) and Lp(a) with our close collaborators from Odyssey Outcomes. OxPL-apoB was reduced predicted MACE in the placebo group, amd interetingly, was a better predictor in people with low, not high.
3
11
50
Check out our new paper out in HF Reviews where we explore alternative pathways for treatment of acute decompensated HF, including emerging treatment strategies including intranasal bumetanide. @AndrewJSauer @UCSDCardiology
@AndrewPAmbrosy
In a primer out in Heart Failure Reviews, we ask a simple question that comes up every clinic day: “Do I really need to be admitted?” for acute decompensated HF. Led by Alexander Hajduczok and Nick Wettersten. We review why hospitalization has become the default for
2
9
18
🚨 New paper from @UCSDCardiology all-star attending Dr. @MattRamsisMD and the UCSD Beacon Center. @hsbhatia @PamTaubMD @MWilkinsonMD
https://t.co/pUU0KQhufH
strokejournal.org
Lipoprotein(a) [Lp(a)] is a genetically determined risk factor for myocardial infarction and stroke1. Elevated Lp(a) >50 mg/dL (>125 nmol/L) is common and present in about 1 in 5 individuals....
0
5
14
🚨 New publication led by Dr. Wettersten: Albuminuria is associated with worse outcomes in non-diabetics hospitalized with acute heart failure @ESC_Journals @ESCHeartFailure @UCSDCardFellows @UCSDHealthSci
https://t.co/xAhqwORcDl
onlinelibrary.wiley.com
Aims Chronic kidney disease (CKD) increases the risk of morbidity and mortality in patients with heart failure (HF). Guidelines recommend assessing CKD using the urinary albumin-to-creatinine ratio...
0
0
1
🚨 New publication led by Dr. Ju Chen: Transcriptional readthrough at Atf4 locus suppresses Rps19bp1 and impairs heart development @UCSDCardFellows @UCSDHealthSci
https://t.co/OLLtyjNEDV
academic.oup.com
AbstractAims. Activating transcription factor 4 (ATF4) functions as a transcriptional regulator in various cell types and tissues under both physiological
0
0
1
#AFibGuideline: We all know our ABCs, but what about the timing? Are we maximizing the benefits of early rhythm control in #AFib? 📣 I am pleased to share this post, the first in the #AFibInsights series, in which @drrakeshg1 and I will answer these questions ℹ️Did you know
0
1
4
Another outstanding annual @UCSDCardiology Pig Heart Dissection! Educational evening learning cardiac anatomy from Dr. Raissi.
0
1
3
💛💙 Fellow Friday! 💛💙 Meet Dr. Rodrigo Rubarth, first-year fellow bringing SoCal surf energy + big smiles to @UCSDCardiology 🌴🌊 📍 Brasília, Brazil 🇧🇷 → 🎓 Georgetown → 🩺 UC San Diego 💡 Favorite thing about UCSD? “Amazing co-fellows and mentors!” ⚽️ Favorite way to get
0
1
5
Happy #CTEPH Awareness Day!💜Remember to think of CTEPH in unexplained dyspnea or persistent sx after a PE. #PTE and #BPA can be life changing for these pts! @ucsdpccm @UCSDCardiology
Dr. Jenny Yang dives into the rare but life-changing world of CTEPH, the only form of pulmonary hypertension that may be curable. Learn why ruling out #CTEPH should be step one for any PH diagnosis. @phaware podcast 546 @UCSDHealth #phawareMD @JennyYangMD
0
2
7
Our new manuscript on the interaction between Lp(a) and IL-6 in primary prevention is out now @JACCJournals. Key points below. @UCSDCardiology @UCSDCardFellows @DrMichaelShapir @RishiRikhiMD @Lpa_Doc @ASPCardio @FamilyHeartFdn
https://t.co/vGjkOfXy8c
6
24
87
Amazing work @ROcher_MD ! Thank you for your hard work and dedication to these projects @UCSDCardiology @UCSDHealth
Honored to present our work from the Beacon Group and @UCSDCardFellows at #AHA25 this weekend. Grateful for the incredible mentorship and support that made this possible! @MWilkinsonMD @PamTaubMD @hsbhatia @MattRamsisMD @AntoinetteBirs
0
3
6
Honored to present our work from the Beacon Group and @UCSDCardFellows at #AHA25 this weekend. Grateful for the incredible mentorship and support that made this possible! @MWilkinsonMD @PamTaubMD @hsbhatia @MattRamsisMD @AntoinetteBirs
1
6
15
Work on Lp(a) testing from UC San Diego BEACON led by @MattRamsisMD highlighted in a talk about Lp(a) by @DrM_ODonoghue #AHA25
@UCSDCardiology @UCSDCardFellows @MWilkinsonMD @PamTaubMD @AHAScience
2
4
30
💛💙 Fellow Friday! 💛💙 From Boston beats to Pacific miles 🏃♀️— meet Dr. Yusi Gong, first-year fellow bringing brilliance and balance to @UCSDCardiology 🌴 📍 Acton, MA → 🎓 Carle Illinois College of Medicine → 🩺 Beth Israel Deaconess → 🌊 San Diego 💡 “Wonderful co-fellows
0
1
9
